Literature DB >> 10423393

Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?

S P Sanders1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423393     DOI: 10.1165/ajrcmb.21.2.f158

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  16 in total

Review 1.  The role of inflammation in childhood asthma.

Authors:  F Chedevergne; M Le Bourgeois; J de Blic; P Scheinmann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

Review 2.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 3.  Nitric oxide metabolism in asthma pathophysiology.

Authors:  Sudakshina Ghosh; Serpil C Erzurum
Journal:  Biochim Biophys Acta       Date:  2011-06-21

4.  Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats.

Authors:  Siddharth Sukumaran; Eve-Irene Lepist; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

Review 5.  New Insights in Oxidant Biology in Asthma.

Authors:  Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2016-03

6.  NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response.

Authors:  R A Dweik; S A Comhair; B Gaston; F B Thunnissen; C Farver; M J Thomassen; M Kavuru; J Hammel; H M Abu-Soud; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Socioeconomic status associated with exhaled nitric oxide responses to acute stress in children with asthma.

Authors:  Edith Chen; Robert C Strunk; Leonard B Bacharier; Meanne Chan; Gregory E Miller
Journal:  Brain Behav Immun       Date:  2009-12-02       Impact factor: 7.217

8.  Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity.

Authors:  Sophie Lanone; Philippe Manivet; Jacques Callebert; Jean-Marie Launay; Didier Payen; Michel Aubier; Jorge Boczkowski; Alexandre Mebazaa
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

9.  CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.

Authors:  Younes J Errahali; Equar Taka; Barack O Abonyo; Ann S Heiman
Journal:  J Interferon Cytokine Res       Date:  2009-04       Impact factor: 2.607

10.  Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors.

Authors:  Erik P Erdal; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2007-06-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.